Mr Mark Brooks

KANDO id: 25082

Bio

Mark J. Brooks, Managing Director, leads investments in the healthcare services, medical device and drug development industries for Scale Venture Partners. Mark is ScaleVP's representative on the Board of Directors for Alimera Sciences (NASDAQ: ALIM), Century Hospice,In-Patient Consultants Management, Inc., LivHome, Inc., National Healing Holding Corporation, Oraya Therapeutics and Spinal Kinetics, Inc. He is responsible for the firm's successful investments in Cardiac Pathways, Cygnal Integrated Products, Rita Medical and U.S. Healthworks. Mark joined the Investment Team in 1995. Prior to joining ScaleVP, he was a Senior Associate for Mercer Management Consulting, where he led projects in the healthcare and telecommunications sectors. Prior to Mercer, he served as a Loan Officer in the Media Group of Manufacturers Hanover Trust Company, where he provided LBO and acquisition capital to cable, entertainment and publishing companies. B.A. in Economics from Dartmouth College and an M.B.A. in Finance and Entrepreneurial Management from The Wharton School at the University of Pennsylvania.

Career


Scale Management LLC

Early-stage venture capital firm that invests in Series A and Series B rounds.
Email: [email protected]

BA Venture Partners

Email: [email protected]

Education